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Background: Plasmodium knowlesi malaria causes severe disease in up to 10% of cases in Malaysian Borneo and
has a mortality rate of 1 - 2%. However, laboratory markers with the ability to identify patients at risk of developing
complications have not yet been assessed as they have for other species of Plasmodium.
Methods: A case control study was undertaken in two hospitals in Sarikei and Sibu, Malaysian Borneo. One
hundred and ten patients with uncomplicated (n = 93) and severe (n = 17) P. knowlesi malaria were studied.
Standardized pigment-containing neutrophil (PCN) count, parasite density and platelet counts were determined
and analysed by logistic regression and receiver operating characteristic (ROC) analysis.
Results: The PCN count was strongly associated with risk of disease severity. Patients with high parasite density
(≥ 35,000/μl) or with thrombocytopaenia (≤ 45,000/μl) were also more likely to develop complications (odds ratio
(OR) = 9.93 and OR = 5.27, respectively). The PCN count yielded the highest area under the ROC curve (AUC)
estimate among all markers of severity (AUC = 0.8561, 95% confidence interval: 0.7328, 0.9794). However, the
difference between all parameter AUC estimates was not statistically significant (Wald test, p = 0.73).
Conclusion: Counting PCN is labour-intensive and not superior in predicting severity over parasitaemia and platelet
counts. Parasite and platelet counts are simpler tests with an acceptable degree of precision. Any adult patient
diagnosed with P. knowlesi malaria and having a parasite count ≥35,000/μl or ≥1% or a platelet count ≤45,000/μl
can be regarded at risk of developing complications and should be managed according to current WHO guidelines
for the treatment of severe malaria.
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Human infection with Plasmodium knowlesi was thought
to be a rare event until an unexpected high incidence
of cases was revealed in the Kapit division of Sarawak,
Malaysian Borneo in 2004 [1]. Subsequent reports of
mixed and mono-infections with P. knowlesi from other
locations in Sarawak and Sabah, Malaysian Borneo [2],
and also from Vietnam, Myanmar, Thailand and the
Philippines show a much wider distribution than initially* Correspondence: jcs26@st-andrews.ac.uk
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reproduction in any medium, provided the orpresumed [3-7]. A clinical cohort study on adult patients
demonstrated a severity rate of up to 10% and a case
fatality rate about 2% [8]. Typical complications include
respiratory distress, jaundice and acute renal failure
which are features of multiple organ failure also seen in
adult Plasmodium falciparum infections [9]. In contrast,
coma does not appear to be a presenting feature of
P. knowlesi malaria.
Despite a relatively high rate of complications, markers
for identifying P. knowlesi malaria patients at risk of
severe disease have not been properly assessed. However,
higher peripheral blood parasitemia and lower platelet
counts are proposed as markers of severity but precise
cut-offs are not available [8]. The malaria pigmentral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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haemoglobin metabolism by the parasite [10]. As the
intra-erythrocytic life-cycle progresses, haemozoin accu-
mulates and becomes visible in late-stage trophozoites
and schizonts. Haemozoin is released into the peripheral
blood during schizont rupture and is subsequently
removed by monocytes and neutrophils [11]. The
number of pigment-containing white blood cells (WBC)
is a marker of disease severity in P. falciparum malaria
[11,12]. In severe P. falciparum malaria circulating
pigment-containing WBCs are significantly higher than
in uncomplicated cases or healthy controls and are
thought to give a measure of the extent and duration
of infection [13-15] but are not a useful predictor of a
fatal outcome [16].
The association between parasitaemia, platelets and
pigment-containing neutrophils (PCN) and risk of severe
disease in P. knowlesi infections was investigated here.
Cut-offs predictive of the risk of developing severe dis-
ease were computed and the relative merit of each as
diagnostic tool discussed.Methods
Study site and design
This case–control study was conducted in two hospitals
in Sarikei and Sibu, Malaysian Borneo, which have a
population of mostly Iban and Chinese ethnicity. Adult
patients (≥15 years) admitted between July 2007 and
January 2010 were included if they had single-species
P. knowlesi infection, did not suffer from any signifi-
cant comorbidity, were not pregnant and had not taken
antimalarial treatment within the previous 28 days. At
admission, routine haematological testing was per-
formed by using fully automatic Nihon Kohden analyzer
(Model 8222, Japan) in Sibu hospital and a Sysmex
KX-21 (Japan) or Nihon Kohden analyzer (Model-MEK
6410K, Japan) in Sarikei hospital. Patients with uncom-
plicated P. knowlesi malaria were treated promptly as
described elsewhere [8,17]. Patients presenting with or
developing features of severe malaria were treated in
compliance with WHO guidelines for severe malaria
[18]. Plasmodium species was confirmed by nested
polymerase chain reaction (PCR) assays at the Malaria
Research Centre, Universiti Malaysia Sarawak, Kuching,
as described previously [1]. Only patients with PCR-
confirmed single-species infection with P. knowlesi were
included in the study. Blood samples, blood films and
clinical data were collected following written informed
consent. The consent forms and the study protocol
have been approved by the Malaysian Ministry of
Health’s Medical Research and Ethics Committee. All
cases with severe disease were retrospectively identified
and included (n = 17). Controls were randomly chosenfrom the pool of patients with uncomplicated malaria
(n = 93).
Classification of severe malaria cases was based on
criteria of the World Health Organization (WHO)
[18,19]. Hyperparasitaemia at any level was not used
as a criterion for severity in this study since an appro-
priate cut-off for hyperparasitaemia has not yet been
assessed for P. knowlesi malaria. Moreover, defining a
specific cut-off for hyperparasitaemia in P. knowlesi
malaria was an objective of this study. Uncomplicated
cases were defined on the basis of symptoms leading to
treatment-seeking behavior in the absence of criteria for
severity based on organ involvement. Classification was
based on clinical and laboratory parameters gained at
hospital admission.
Malaria pigment assessment
Thin blood films were stained with 10% Giemsa Gurr`s
improved R66 (BDH Chemicals LTD, Poole, UK) for
25 minutes after fixation with methanol (Methanol,
Merck, Darmstadt, Germany) for 1 min. Peripheral para-
site density was determined from thin blood films by
counting the number of asexual forms in eight consecu-
tive microscopic fields, assuming 250 red blood cells per
field in an area with regular monolayer and 1,000-fold
magnification. Results are given in percent infected red
blood cells (IRBC). Standard parasite counts of thick
blood films were quantified as follows: number of asexual
forms per 500 WBCs x actual WBCs/μl/500. If parasit-
aemia was high, asexual forms per 200 WBCs were
counted. Differential counts were conducted manually
on thin blood films for each patient.
For a reliable identification of cell morphology, PCN
were detected exclusively on thin blood films by counting
100 neutrophils using an Olympus BX53 microscope
with 1000-fold magnification (Figure 1). Subsequently,
the percentage of PCN was determined. Two patients
were excluded from the study when WBC on the blood
films were not identifiable because of poor slide prep-
aration or poor staining. The microscopist was blinded
to selection criteria, clinical data and outcome. To inves-
tigate intra-observer reliability with regards to the PCN
count, 10% of the samples were re-examined by the same
microscopist, using another code on the slides. Due to
variable WBC counts among the study group, it was
necessary to standardize total pigment burden of neutro-
phils as described previously [13]. Briefly, PCN/μl was
calculated as follows: PCN/μl = (number of PCN/100
neutrophils) × (absolute WBC/μl × percent of neutrophils).
Statistical methods
Baseline characteristics and laboratory findings with
numerical outcomes were described on the basis of
means and 95% confidence intervals (CI) when data were
Figure 1 Giemsa-stained thin blood films. Amber intracellular haemozoin (arrows) within neutrophils from three different patients with
Plasmodium knowlesi malaria (A-C).






Multiple convulsions – more
than two episodes in 24 h
0 (0)
Clinical jaundice plus kidney injury
(serum creatinine > 265 μmol/l)
6 (35.3)
Deep breathing, respiratory distress
(> 30 breath/min)
3 (17.6)
Circulatory collapse or shock, systolic
blood pressure < 70 mm Hg in adults
1 (5.9)
Abnormal spontaneous bleeding 0 (0)
Kidney injury (serum creatinine > 265 μmol/l) 16 (94.1)
Severe normocytic anaemia
(packed cell volume < 15%)
1 (5.9)
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with an unpaired t-test. For skewed data, medians and
interquartile ranges were presented. When transform-
ation could achieve normal distribution of values a
t-test was subsequently used. Otherwise the Wilcoxon
rank sum test was employed. D'Agostino's K-squared test
was used to check for normality.
Linear regression analysis was performed on numerical
outcomes. Heteroskedasticity was tested by using the
Breusch-Pagan and Cook-Weisberg tests and when
positive robust standard errors were calculated. Odds
ratios (OR) were calculated for categorical variables by
using logistic regression. For testing the overall associ-
ation of categorical variables and risk of severity, a likeli-
hood ratio test was performed. Possible interaction
between variables within multivariate logistic regression
models was also checked by the use of the likelihood
ratio test. Variables were only included into multivariate
logistic regression when they were unlikely to lie on the
same causal pathway towards the outcome of interest.
A possible application of severity markers as diagnostic
tools was determined by receiver-operating characteristic
(ROC) analyses. For every possible predictor, the area
under the ROC curve (AUC) was computed and com-
pared to other predictors by using the Wald test and
following an algorithm suggested by DeLong, DeLong
and Clarke-Pearson [20]. Since it is necessary in ROC
analysis to use a diagnostic rating with increasing values
indicating a higher risk, the platelet count could not be
directly applied and the inverse function was used. AUC
ranges from 0.5 (diagnosis is based simply on chance)
to 1 (highest precision). Cut-offs were obtained by exam-
ining any value of the ROC curve with regard to its sensi-
tivity and specificity and subsequently predictive values
were calculated.
Interclass correlation coefficient was used to assess
intra-observer reliability in reading 10% of the thin films
by the same microscopist for a second time. A P < 0.05
(two-sided) was regarded as statistically significant. All
analyses were made by using Stata version 11.0 (Stat
Corp., College Station, TX, USA).Results
Demographic characteristics and baseline laboratory
findings
A total number of 110 patients were included in the
study. According to the WHO criteria for severe fal-
ciparum malaria [18,19], 17 patients were classified as
severe cases with four fatalities. The most common
complication was renal failure (94.1%, Table 1). Demo-
graphic features and laboratory findings are listed in
Table 2. Both patient groups tend to have a normal
WBC count with a slightly higher leukocyte number in
patients with severe malaria (p = 0.009). Differences
amongst both study groups were noted for potential la-
boratory markers of severity. The median PCN count was
higher in patients with severe malaria (563 vs 36 PCN/μl,
p <0.0001). Ten per cent of the films were re-examined
and an interclass correlation coefficient of 0.7883 for
the PCN count was determined. Thick and thin film
parasite counts were also significantly different (94256 vs
3843.5 parasites/μl, p <0.0001, and 2.5% vs 0.3%,
p <0.0001). One hundred and seven patients (97.3%)
had thrombocytopaenia (<150,000 platelets/μl). However,
the maximum platelet count in the study cohort was
Table 2 Demographic characteristics and laboratory findings of adult patients with Plasmodium knowlesi malaria
Variable Uncomplicated malaria n = 93 Severe malaria n = 17 p-value
Demographic characteristic
Age, mean (95% CI), years 43.44 (40.4 – 46.5) 49.59 (43.24 – 55.94) 0.11
Male sex, % 68.8 70.6 NA
Iban ethnicity, % 81.7 88.2 NA
Laboratory findings at admission
White blood cell count, x 103/μl1 5.9 (5 – 7.55) 8.7 (6.7 – 12.5) 0.009
Neutrophils, mean (95% CI), % 70.4 (68.8 – 71.9) 75.1 (69.9 – 80.4) 0.025
Monocytes, %1 2 (1 – 5) 3 (2 – 4) 0.69
Lymphocytes, mean (95% CI), % 25.2 (23.8 – 26.6) 21.2 (16.4 – 26) 0.034
Parasite count, parasites/μl1 3843.5 (714.5 – 13030.5) 94256 (18432 – 285768) <0.0001
Parasite count, % IRBC1 0.3 (0.1- 0.7) 2.5 (0.7 – 11.1) <0.0001
Platelet count, x 103 platelets/μl1 69 (44 – 99) 38 (26 – 48) 0.0004
PCN count, cells/μl1 36 (0–128) 563 (158 – 1388) <0.0001
1 median, interquartile range.
95% CI 95% confidence interval.
% IRBC % infected red blood cells.
PCN pigment-containing neutrophils.
NA not assessed.
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let count in all of the patients. Platelet counts were
lower in severe P. knowlesi malaria compared with
uncomplicated disease (38,000 vs 69,000 platelets/μl,
p = 0.0004).
Risk assessment of potential laboratory severity markers
A detailed crude risk assessment of potential labora-
tory severity markers was performed by using logistic
regression on different categorical variables (Table 3).
The PCN count was strongly associated with risk ofTable 3 Risk of severe disease among adult patients with Pla
Variable Uncomplicated malaria n
PCN count (PCN/μl) 0 41 (44.1)
1 – 139 32 (34.4)
140 – 415 14 (15.1)
≥416 6 (6.4)
Parasite count (parasites/μl) <100000 85 (91.4)
≥100000 8 (8.6)
Parasite count (% IRBC) <2 80 (86)
≥2 13 (14)
Platelet count (x 103 platelets/μl) ≥60 54 (58.1)
36-59 18 (19.3)
≤35 21 (22.6)
95% CI 95% confidence interval.
PCN pigment-containing neutrophils.
% IRBC % infected red blood cells.
†All p-values were obtained from likelihood ratio test.severity (p <0.0001). This is particularly accentuated in
the group with the highest PCN count (≥416 PCN/μl,
OR = 37.58). For analysis of the parasite counts the
WHO cut-offs for severe falciparum malaria in low
transmission areas were employed (thick film count
>100,000 parasites/μl and thin film count >2% IRBC).
Both were strongly associated with risk of severity (OR =
9.44 and OR = 8.79, respectively). Furthermore, patients
with severe (≤35,000 platelets/μl) and moderate (36,000
platelets/μl – 59,000 platelets/μl) thrombocytopaenia were
more likely to have a severe course of disease (p = 0.001).smodium knowlesi malaria – univariate modeling
(%) Severe malaria n (%) Crude odds ratio (95% CI) p-value†
2 (11.8) 1 <0.0001
1 (5.9) 0.64 (0.06 – 7.38)
3 (17.6) 4.39 (0.66 – 29.06)
11 (54.7) 37.58 (6.64 – 212.67)
9 (52.9) 1 0.0003
8 (47.1) 9.44 (2.85 – 31.28)
7 (41.2) 1 0.0001
10 (58.8) 8.79 (2.84 – 27.21)
2 (11.8) 1 0.001
8 (47) 12 (2.33 – 61.78)
7 (41.2) 9 (1.72 – 46.87)
Table 4 Linear regression analysis of the predictive markers
Dependent variable Independent variable Coefficient (95% CI) p value R2
PCN count (PCN/μl) Parasite count (% IRBC) 148.19 (95.1 – 201.27) <0.0001 0.75
PCN count (PCN/μl) Parasite count (parasites/μl) 0.005 (0.004 – 0.006) 0.0003 0.65
Platelet count (x 103 platelets/μl) Parasite count (% IRBC) −2.24 (−3.79 – -0.7) 0.005 0.07
Platelet count (x 103 platelets/μl) Parasite count (parasites/μl) −0.00007 (−0.0001 – -0.00001) 0.002 0.05
Platelet count (x 103 platelets/μl) PCN count (PCN/μl) −0.01 (−0.19 – -0.0009) 0.031 0.04
95% CI 95% confidence interval.
PCN pigment-containing neutrophils.
% IRBC % infected red blood cells.
R2 square of correlation coefficient.
Table 5 Risk of severe disease among adult patients with
Plasmodium knowlesi malaria – multivariate modeling
Model Variables Adjusted OR
(95% CI)
p value†
Model 1 Platelet count ≥60 1
(x 103 platelets/μl) 36-59 10.37 (1.79 – 59.98) 0.002
≤35 12.28 (2.04 – 73.86)
Parasite count <100000 1 0.0006
(parasites/μl) ≥100000 10.74 (2.63 – 43.94)
Model 2 Platelet count ≥60 1
(x 103 platelets/μl) 36-59 8.69 (1.59 – 47.48) 0.018
≤35 5.59 (0.99 – 31.34)
Parasite count <2 1 0.003
(% IRBC) ≥2 5.97 (1.79 – 19.88)
Model 3 Platelet count ≥60 1
(x 103 platelets/μl) 36-59 4.75 (0.74 – 30.36) 0.04
≤35 9.29 (1.37 – 62.86)
PCN count 0 1
(PCN/μl) 1 – 139 0.54 (0.04 – 6.63) <0.0001
140 – 415 4.8 (0.66 – 34.83)
≥416 30.25 (4.74 – 193.22)
95% CI 95% confidence interval.
PCN pigment-containing neutrophils.
% IRBC % infected red blood cells.
†All p-values were obtained from likelihood ratio test.
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of potential severity markers
Linear regression was performed on the potential sever-
ity markers to investigate associations between them.
The results indicate that peripheral parasitaemia mea-
sured on thick and thin blood films accounts for 75%
and 65% (R2 = 0.75 and 0.65 respectively) of the total
variation in circulating pigment-containing neutrophils
(Table 4). Since both variables might lie on the same
causal pathway towards the outcome, they were not
included in the same multivariate logistic regression
model. However, the variation of the platelet count can-
not be explained for the most part by the changes in
peripheral parasitaemia (R2 = 0.07 and 0.05 respectively)
or amount of circulating pigment-containing neutrophils
(R2 = 0.04) and is thus unlikely to lie on the same causal
pathway towards the outcome. To address these issues,
three different multivariate models were performed. The
results are shown in Table 5. There is some degree of
confounding but the platelet count proves to be an inde-
pendent predictor of severity when corrected for the
effects of peripheral parasitaemia and circulating PCN.
Diagnostic precision of severity markers
A possible diagnostic employment of any marker asso-
ciated with risk of severity depends fundamentally on its
precision to diagnose the outcome of interest. Therefore,
ROC analyses were performed on PCN, percent parasit-
aemia (thin blood film), parasite/μl (thick blood film)
and platelet counts as potential laboratory markers of se-
verity as identified during risk assessment (Figure 2,
Tables 3 and 5). The PCN count yielded the highest esti-
mate of precision (AUC = 0.8561) whereas the platelet
count showed to be the least precise in diagnosing sever-
ity (AUC = 0.7723). These results are shown in Table 6.
However, despite these distinct estimates there is no
evidence that precision differs between PCN, thin and
thick film parasite count and platelet count (Wald test,
p = 0.73).
Suitable cut-offs for practical use were evaluated for
thick and thin film parasite counts and for platelet
counts (Table 7). Candidates for cut-offs were chosen atpoints of substantial changes in sensitivity and specificity
during ROC analysis. Positive and negative predictive
values were calculated by assuming a prevalence of 10%
severe cases among hospitalized patients with P. knowlesi
malaria. Such prevalence was reported from a prospect-
ive survey in Sarawak, Malaysia [8]. A minimum negative
predictive value of 95% was required to be recommended
as suitable cut-off. Cut-offs can be used to categorize
patients into groups of higher and lower risk of severe
P. knowlesi malaria. For example, any patient having a
parasite count ≥35,000/μl or ≥1% parasitaemia can be
regarded to be at high risk of severe disease. Multivariate
risk assessment of severity markers when using the
recommended cut-offs is shown in Table 8. Both
Figure 2 Area under the ROC curve (AUC) estimates of severity markers. Receiver-operating characteristic (ROC) analysis revealed no
difference in diagnostic potential between all parameters.
Table 6 Receiver operating characteristic (ROC) analysis
of severity markers in patients with Plasmodium knowlesi
malaria
Variable AUC (95% CI)
Pigment-containing neutrophil
count in cells/μl
0.8561 (0.7328 – 0.9794)
Parasite count in parasites/μl (thick film) 0.8261 (0.7075 – 0.9447)
Parasite count in % IRBC (thin film) 0.8476 (0.7536 – 0.9416)
Platelet count in x 103 platelets/μl† 0.7723 (0.6775 – 0.8671)
AUC area under ROC curve.
95% CI 95% confidence interval.
% IRBC % infected red blood cells.
NA not assessed.
†This analysis was made on the inverse function of the platelet count.
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severity when using the suggested cut-offs instead of the
WHO cut-offs of >100,000 parasites/μl or >2% IRBC for
P. falciparum malaria. Having a platelet count ≤45,000/μl
is independently associated with a higher risk of severity
(OR = 5.27; p = 0.004).
Discussion
Since P. knowlesi malaria causes severe disease in ap-
proximately one of 10 patients and can be potentially
fatal [8], the search for reliable and unsophisticated
markers of disease severity that complement the diagno-
sis of malaria needs to be intensified. The objectives of
the study presented here were to test for an association
between pigment-containing neutrophil counts and risk
of disease severity and to compare with parasitaemia
and platelet counts as predictors of severe P. knowlesi
malaria. Pigment-containing monocytes are also a marker
of severe P. falciparum malaria [12]. However, due to the
low number of monocytes found in thin blood films, a
count of 100 monocytes is highly time consuming and
was considered as an impractical procedure for routine
use and was therefore not performed here.
A strong association between PCN count and risk of
disease severity was observed. The method involved
counting 100 neutrophils, took 15–20 minutes and
requires skilled personal to identify the correct cell
morphology. It is both labour-intensive and time con-
suming in the routine malaria diagnostic setting. There-
fore, the PCN count should have a superior prognostic
ability over parasitaemia and platelet counts if it is to
be recommended for routine use. Even though the
AUC estimate for PCN was the highest among all par-
ameter estimates, PCN counts did not have a higherdiagnostic precision when compared with parasite and
platelet counts. The lack of statistical significance might
be explained by the low sample size. On the other
hand, linear regression analysis revealed that the total
variation in the amount of pigment-containing neutro-
phils can be explained by the changes in peripheral
parasitaemia to an extent of up to 75%, leaving only a
minor proportion in the total variation that might rep-
resent sequestration and would give additional prognos-
tic information in P. knowlesi malaria. In any case, the
observed differences in the AUC estimates are rather
small and cannot justify a recommendation of the PCN
counts as a routine test at the moment. Flow cytometry
can achieve a fast and effective detection of pigment-
containing WBCs [15,21] but remains a future ap-
proach in most settings.
In contrast, the parasite count on thick and thin
blood films is a simpler method and is usually avail-
able in resource-poor settings. The peripheral blood
Table 7 Cut-off evaluation of predictive markers
Variable Cut-off Sensitivity (%) Specificity (%) PPV (%) NPV (%) Odds of severity
Parasite count (parasites/μl) ≥20000 70.59 79.57 27.74 96.05 0.63
Parasite count (parasites/μl) ≥35000 64.71 84.95 32.33 95.59 0.79
Parasite count (parasites/μl) ≥50000 58.82 87.1 33.6 95 0.83
Parasite count (parasites/μl) ≥100000 47.06 91.4 37.81 93.95 1
Parasite count (% IRBC) ≥0.5 88.24 65.59 22.17 98.05 0.47
Parasite count (% IRBC) ≥0.8 70.59 76.34 24.89 95.89 0.54
Parasite count (% IRBC) ≥1 64.71 78.49 25.05 95.24 0.55
Parasite count (% IRBC) ≥2 58.82 86.02 31.86 94.95 0.77
Parasite count (% IRBC) ≥3 47.06 89.25 32.72 93.82 0.8
Platelet count (x 103 platelets/μl) ≤60 88.24 55.91 18.19 97.72 0.37
Platelet count (x 103 platelets/μl) ≤50 76.47 68.82 21.41 96.34 0.45
Platelet count (x 103 platelets/μl) ≤45 70.59 72.04 21.91 95.66 0.46
Platelet count (x 103 platelets/μl) ≤40 58.82 76.34 21.64 94.35 0.46
% IRBC % infected red blood cells.
PPV positive predictive value.
NPV negative predictive value.
Bolded rows indicate the recommended cut-offs.
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potential marker of severity in P. knowlesi malaria [8].
The authors of the same study revealed an inverse cor-
relation between parasitaemia and platelet count and
suggested that the latter could also be a predictive factor.
The number of severe cases in that study was small and
the findings were confirmed here, even if the platelet
count seems to have a lower accuracy in predicting
severe disease when compared with PCN counts and
parasitaemia.
Assessing cut-offs with a more predictive than reflective
capability was based on an appropriate relationship be-
tween positive and negative predictive values. Recom-
mendation of a specific cut-off required a negative
predictive value of at least 95% in the study. This would
mean that one in 20 patients with a test result indicating
non-severe disease or a low risk of developing complica-
tions would have severe disease at the time of measure-
ment. None of the severity markers could reach highTable 8 Risk of severe disease in patients with Plasmodium kn
cut-offs – multivariate modeling
Variable Uncomplicated malaria n (%
Parasite count (parasites/μl) <35000 79 (71.8)
≥35000 14 (28.2)
Parasite count (% IRBC) <1 73 (78.5)
≥1 20 (21.5)
Platelet count (x 103 platelets/μl) >45 67 (72)
≤45 26 (28)
95% CI 95% confidence interval.
% IRBC % infected red blood cells.
†All p-values were obtained from likelihood ratio test.
*The odds ratio was obtained by including the platelet count into one model withpositive predictive values in the study, assuming a preva-
lence of 10% severe cases among hospitalized patients
with P. knowlesi malaria. A positive predictive value of
about 33% as calculated for the recommended cut-off of
35,000 parasites/μl means that two of three patients with
a positive test indicating a severe disease or a high risk of
developing complications would not suffer from severe
malaria at the time of measurement. Managing them
according to the WHO guidelines for severe malaria
might appear as an overtreatment and potential waste of
resources in an often resource-limited setting. However,
when using the recommended cut-offs in multivariate
logistic regression analysis any tested severity marker is
independently associated with high risk of severity (OR
5.27 – 9.93). Therefore, having a positive test result in
accord with the recommended cut-offs categorizes a
patient to be at high risk of severity regardless of the
actual clinical status. Management for severe malaria
should consecutively be accomplished to prevent aowlesi malaria using the recommended
) Severe malaria n (%) Adjusted odds ratio (95c% CI) p-value†
6 (35.3) 1 0.0001
11 (64.7) 9.93 (2.91 – 33.87)
6 (35.3) 1 0.003
11 (64.7) 5.72 (1.78 – 18.37)
5 (29.4) 1 0.004
12 (70.6) 5.27 (1.59 – 17.41)*
parasite count (% IRBC) measured on thin blood films.
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within this high-risk group even if they do not suffer
from complications at the time of measurement. Conse-
quently, the results of the study presented here indicate
that any adult patient diagnosed with P. knowlesi mal-
aria and a parasite count ≥35,000/μl or ≥1% or a plate-
let count ≤45,000/μl should be regarded at risk and
should subsequently be treated as for severe malaria
according to current WHO guidelines.
Using these cut-offs in areas with prevalence of both
P. knowlesi and Plasmodium malariae may be an issue.
Plasmodium knowlesi is often confused with P. malariae
when making the diagnosis by light microscopy [22].
Plasmodium malariae infection causes a median para-
sitaemia of 8,875 parasites/μl with maximum of about
50,000 parasites/μl [23], but rarely causes severe disease.
P. knowlesi may be wrongly diagnosed in the presence of
a P. malariae infection. In such cases, a parasite count
≥35,000/μl alone may lead to incorrect risk estimation
although coupled with low platelet counts may be more
specific. In Sarawak and Sabah, P. malariae infection
is rare [2,24] and the benefit of properly diagnosing
P. knowlesi would override misdiagnosing P. malariae
in a small number of cases.
One major limitation of this study is the assumption
that severe cases of P. knowlesi malaria occur with a
prevalence of 10% among hospitalized patients. The preva-
lence and characteristics of P. knowlesi malaria should
be measured within the framework of prospective studies
in all locations in Southeast Asia where P. knowlesi
malaria occurs [3-6] and where validation of the findings
presented here would be informative. Cut-offs might be
adjusted according to the results gained in such studies.
The analyses conducted here identify parasitaemia and
platelet counts as measures of risk assessment for the
development of severe disease in P. knowlesi infections.
However, additional simple diagnostic tools to distin-
guish P. knowlesi from P. malariae infections in settings
with limited resources are urgently needed to identify
patients at risk of severe P. knowlesi malaria.
Conclusion
Based on the results obtained, parasite and platelet
counts are precise tests for indentifying patients at risk
of severe P. knowlesi malaria. Counting PCN is not su-
perior in predicting severity but labour-intensive and can
therefore not be recommended for routine diagnosis of
P. knowlesi infections.
Competing interests
The authors declare that they have no competing interests.
Authors’ contribution
MW, AA, AS, ITW and LCW collected the blood samples and patients’ data.
MW, AA and AS carried out the laboratory work. MW participated in the
design of the study and analysed the data. JCS, BS and SK conceived thestudy and participated in its coordination. MW and JCS wrote the
manuscript. All authors read, commented on and approved the final
manuscript.
Acknowledgements
We thank the directors, doctors, laboratory and nursing staff of the medical
wards in Sarikei and Sibu Hospital, and Mr Wong and Mr Pek at Sibu Hospital
for assistance and support; and the patients who participated this study. We
would like to thank Miss Sarina Kaur Singh-Khaira for assistance with data
entry. This study was funded by the Medical Research Council (MRC) UK;
Grant number G0801971, and the London School of Hygiene and Tropical
Medicine (Trust Funds award).
Author details
1Institute of Medical Microbiology and Hygiene, University of Tübingen,
Tübingen, Germany. 2Malaria Research Centre, University Malaysia Sarawak,
Kuching, Sarawak, Malaysia. 3Hospital Sibu, Sibu, Sarawak 96000, Malaysia.
4Pathology Laboratory, Hospital Sarikei, Sarikei, Sarawak 96100, Malaysia.
5Division of Clinical Sciences, St. George’s, University of London, London, UK.
6School of Medicine, University of St Andrews, Medical and Biological
Sciences Building, North Haugh, St Andrews KY16 9TFFife, UK.
Received: 26 June 2012 Accepted: 18 October 2012
Published: 30 October 2012
References
1. Singh B, Kim Sung L, Matusop A, Radhakrishnan A, Shamsul SS, Cox-Singh J,
Thomas A, Conway DJ: A large focus of naturally acquired Plasmodium
knowlesi infections in human beings. Lancet 2004, 363:1017–1024.
2. Cox-Singh J, Davis TM, Lee KS, Shamsul SS, Matusop A, Ratnam S, Rahman
HA, Conway DJ, Singh B: Plasmodium knowlesi malaria in humans is
widely distributed and potentially life threatening. Clin Infect Dis 2008,
46:165–171.
3. Jiang N, Chang Q, Sun X, Lu H, Yin J, Zhang Z, Wahlgren M, Chen Q:
Co-infections with Plasmodium knowlesi and other malaria parasites,
Myanmar. Emerg Infect Dis 2010, 16:1476–1478.
4. Jongwutiwes S, Putaporntip C, Iwasaki T, Sata T, Kanbara H: Naturally
acquired Plasmodium knowlesi malaria in human, Thailand. Emerg Infect
Dis 2004, 10:2211–2213.
5. Luchavez J, Espino F, Curameng P, Espina R, Bell D, Chiodini P, Nolder D,
Sutherland C, Lee KS, Singh B: Human Infections with Plasmodium
knowlesi, the Philippines. Emerg Infect Dis 2008, 14:811–813.
6. Van den Eede P, Vythilingam I, Ngo DT, Nguyen VH, Le XH, D'Alessandro U,
Erhart A: Plasmodium knowlesi malaria in Vietnam: some clarifications.
Malar J 2010, 9:20.
7. Sermwittayawong N, Singh B, Nishibuchi M, Sawangjaroen N, Vuddhakul V:
Human Plasmodium knowlesi infection in Ranong province,
southwestern border of Thailand. Malar J 2012, 11:36.
8. Daneshvar C, Davis TM, Cox-Singh J, Rafa'ee MZ, Zakaria SK, Divis PC, Singh
B: Clinical and laboratory features of human Plasmodium knowlesi
infection. Clin Infect Dis 2009, 49:852–860.
9. Timothy William JM, Giri R, Leslie C, Gordon M, Samantha D, Serena K,
Charlie F, Jenarun J, Anstey NM, Tsin Wen Y: Severe Plasmodium knowlesi i
malaria in a tertiary care hospital, Sabah, Malaysia. Emerg Infect Dis 2011,
17:1248–1255.
10. Sherman IW: Amino acid metabolism and protein synthesis in malarial
parasites. Bull World Health Organ 1977, 55:265–276.
11. Hanscheid T, Egan TJ, Grobusch MP: Haemozoin: from melatonin pigment
to drug target, diagnostic tool, and immune modulator. Lancet Infect Dis
2007, 7:675–685.
12. Nguyen PH, Day N, Pram TD, Ferguson DJ, White NJ: Intraleucocytic
malaria pigment and prognosis in severe malaria. Trans R Soc Trop Med
Hyg 1995, 89:200–204.
13. Lyke KE, Diallo DA, Dicko A, Kone A, Coulibaly D, Guindo A, Cissoko Y,
Sangare L, Coulibaly S, Dakouo B, Taylor TE, Doumbo OK, Plowe CV:
Association of intraleukocytic Plasmodium falciparum malaria pigment
with disease severity, clinical manifestations, and prognosis in severe
malaria. AmJTrop Med Hyg 2003, 69:253–259.
14. Amodu OK, Adeyemo AA, Olumese PE, Gbadegesin RA: Intraleucocytic
malaria pigment and clinical severity of malaria in children. Trans R Soc
Trop Med Hyg 1998, 92:54–56.
Willmann et al. Malaria Journal 2012, 11:363 Page 9 of 9
http://www.malariajournal.com/content/11/1/36315. Hanscheid T, Langin M, Lell B, Potschke M, Oyakhirome S, Kremsner PG,
Grobusch MP: Full blood count and haemozoin-containing leukocytes in
children with malaria: diagnostic value and association with disease
severity. Malar J 2008, 7:109.
16. Kremsner PG, Valim C, Missinou MA, Olola C, Krishna S, Issifou S, Kombila M,
Bwanaisa L, Mithwani S, Newton CR, Agbenyega T, Pinder M, Bojang K,
Wypij D, Taylor T: Prognostic value of circulating pigmented cells in
African children with malaria. J Infect Dis 2009, 199:142–150.
17. Daneshvar C, Davis TM, Cox-Singh J, Rafa'ee MZ, Zakaria SK, Divis PC, Singh
B: Clinical and parasitological response to oral chloroquine and
primaquine in uncomplicated human Plasmodium knowlesi infections.
Malar J 2010, 9:238.
18. WHO: Management of severe malaria: a practical handbook. Geneva: WHO
Library Cataloguing; 2011.
19. WHO: Severe falciparum malaria. World Health Organization,
Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000,
94(Suppl 1):1–90.
20. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under
two or more correlated receiver operating characteristic curves: a
nonparametric approach. Biometrics 1988, 44:837–845.
21. Hanscheid T, Frita R, Langin M, Kremsner PG, Grobusch MP: Is flow
cytometry better in counting malaria pigment-containing leukocytes
compared to microscopy? Malar J 2009, 8:255.
22. Cox-Singh J, Singh B: Knowlesi malaria: newly emergent and of public
health importance? Trends Parasitol 2008, 24:406–410.
23. Collins WE, Jeffery GM: Plasmodium malariae: parasite and disease. Clin
Microbiol Rev 2007, 20:579–592.
24. Joveen-Neoh WF, Chong KL, Wong CM, Lau TY: Incidence of malaria in the
interior division of sabah, malaysian borneo, based on nested PCR.
J Parasitol Res 2011, 2011:104284.
doi:10.1186/1475-2875-11-363
Cite this article as: Willmann et al.: Laboratory markers of disease
severity in Plasmodium knowlesi infection: a case
control study. Malaria Journal 2012 11:363.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
